• Thumbnail for COVID-19 drug repurposing research
    Drug repositioning (also known as drug repurposing, re-profiling, re-tasking, or therapeutic switching) is the repurposing of an approved drug for the...
    126 KB (14,698 words) - 12:01, 27 March 2024
  • Drug repositioning (also called drug repurposing) involves the investigation of existing drugs for new therapeutic purposes. Repurposing generics can have...
    17 KB (1,894 words) - 08:28, 3 April 2024
  • estimated that this cocktail could cost over $500. COVID-19 drug repurposing research (ivermectin) COVID-19 misinformation (ivermectin) Science by press release...
    14 KB (1,300 words) - 03:56, 27 September 2023
  • Thumbnail for COVID-19 drug development
    COVID-19 drug development is the research process to develop preventative therapeutic prescription drugs that would alleviate the severity of coronavirus...
    90 KB (13,106 words) - 20:17, 24 March 2024
  • social media by anti-vaccination activists. COVID19 drug development COVID19 drug repurposing research Our World in Data (OWID) vaccination maps. Data...
    192 KB (21,930 words) - 19:29, 15 April 2024
  • Thumbnail for Antiviral drug
    of antiviral drugs Virucide Antiprion drugs and Astemizole Discovery and development of NS5A inhibitors COVID-19 drug repurposing research Antiviral Agents...
    57 KB (6,925 words) - 01:45, 7 January 2024
  • Thumbnail for Ivermectin during the COVID-19 pandemic
    was needed of how medical research was assessed. Big Pharma conspiracy theories COVID-19 drug repurposing research COVID-19 misinformation Chloroquine...
    73 KB (6,787 words) - 01:19, 16 April 2024
  • Thumbnail for COVID-19
    assess the economic impact of the pandemic. Repurposed antiviral drugs make up most of the research into COVID19 treatments. Other candidates in trials include...
    285 KB (32,669 words) - 05:08, 20 April 2024
  • Thumbnail for Pfizer–BioNTech COVID-19 vaccine
    The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company...
    236 KB (19,394 words) - 05:58, 20 April 2024
  • Thumbnail for Oxford–AstraZeneca COVID-19 vaccine
    Retrieved 14 August 2021. "AZN, IQV Team Up To Accelerate COVID-19 Vaccine Work, RIGL's ITP Drug Repurposed, IMV On Watch". RTTNews. Archived from the original...
    211 KB (16,862 words) - 19:31, 11 March 2024